Cargando…
Introducing helmet non-invasive ventilation during COVID-19 pandemic: Early experience of two centres
PURPOSE: The helmet is a novel interface for delivering non-invasive ventilation (NIV). We conducted a case series to characterize introduction of the helmet interface in both COVID and non-COVID patients at two-centres. METHODS: We enrolled all patients with respiratory failure admitted to the Jura...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941518/ https://www.ncbi.nlm.nih.gov/pubmed/36824605 http://dx.doi.org/10.3389/fmed.2023.1075797 |
_version_ | 1784891300718313472 |
---|---|
author | Chaudhuri, Dipayan Sharma, Rishi Burns, Karen E. A. Piticaru, Joshua Cook, Deborah J. Rochwerg, Bram |
author_facet | Chaudhuri, Dipayan Sharma, Rishi Burns, Karen E. A. Piticaru, Joshua Cook, Deborah J. Rochwerg, Bram |
author_sort | Chaudhuri, Dipayan |
collection | PubMed |
description | PURPOSE: The helmet is a novel interface for delivering non-invasive ventilation (NIV). We conducted a case series to characterize introduction of the helmet interface in both COVID and non-COVID patients at two-centres. METHODS: We enrolled all patients with respiratory failure admitted to the Juravinski Hospital (Hamilton, Canada) and St. Joseph’s Health Center (Syracuse, New York) between November 1, 2020 and June 30, 2021 who used the helmet interface (Intersurgical StarMed) as part of this introduction into clinical practice. We collected patient demographics, reason for respiratory failure, NIV settings, device-related complications and outcomes. We report respiratory therapist’s initial experiences with the helmet using descriptive results. RESULTS: We included 16 patients with a mean age of 64.3 ± 10.9 years. The most common etiology for respiratory failure was pneumonia (81.3%). The median duration of NIV during the ICU admission was 67.5 (15.3, 80.8) hours, with a mean maximum PS of 13.9 ± 6.6 cm H2O and a mean maximum PEEP of 10.4 ± 5.1 cm H20. Three patients (18.7%) did not tolerate the helmet. Ten (62.5%) patients ultimately required intubation, and 7 (43.4%) patients died while in the ICU. The most common reason for intubation was worsening hypoxia (70%). No adverse events related to the helmet were recorded. CONCLUSION: Over the 8-month period of this study, we found that the helmet was well tolerated in over 80% of patients, although, more than half ultimately required intubation. Randomized controlled trials with this device are required to fully assess the efficacy of this interface. |
format | Online Article Text |
id | pubmed-9941518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99415182023-02-22 Introducing helmet non-invasive ventilation during COVID-19 pandemic: Early experience of two centres Chaudhuri, Dipayan Sharma, Rishi Burns, Karen E. A. Piticaru, Joshua Cook, Deborah J. Rochwerg, Bram Front Med (Lausanne) Medicine PURPOSE: The helmet is a novel interface for delivering non-invasive ventilation (NIV). We conducted a case series to characterize introduction of the helmet interface in both COVID and non-COVID patients at two-centres. METHODS: We enrolled all patients with respiratory failure admitted to the Juravinski Hospital (Hamilton, Canada) and St. Joseph’s Health Center (Syracuse, New York) between November 1, 2020 and June 30, 2021 who used the helmet interface (Intersurgical StarMed) as part of this introduction into clinical practice. We collected patient demographics, reason for respiratory failure, NIV settings, device-related complications and outcomes. We report respiratory therapist’s initial experiences with the helmet using descriptive results. RESULTS: We included 16 patients with a mean age of 64.3 ± 10.9 years. The most common etiology for respiratory failure was pneumonia (81.3%). The median duration of NIV during the ICU admission was 67.5 (15.3, 80.8) hours, with a mean maximum PS of 13.9 ± 6.6 cm H2O and a mean maximum PEEP of 10.4 ± 5.1 cm H20. Three patients (18.7%) did not tolerate the helmet. Ten (62.5%) patients ultimately required intubation, and 7 (43.4%) patients died while in the ICU. The most common reason for intubation was worsening hypoxia (70%). No adverse events related to the helmet were recorded. CONCLUSION: Over the 8-month period of this study, we found that the helmet was well tolerated in over 80% of patients, although, more than half ultimately required intubation. Randomized controlled trials with this device are required to fully assess the efficacy of this interface. Frontiers Media S.A. 2023-02-07 /pmc/articles/PMC9941518/ /pubmed/36824605 http://dx.doi.org/10.3389/fmed.2023.1075797 Text en Copyright © 2023 Chaudhuri, Sharma, Burns, Piticaru, Cook and Rochwerg. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Chaudhuri, Dipayan Sharma, Rishi Burns, Karen E. A. Piticaru, Joshua Cook, Deborah J. Rochwerg, Bram Introducing helmet non-invasive ventilation during COVID-19 pandemic: Early experience of two centres |
title | Introducing helmet non-invasive ventilation during COVID-19 pandemic: Early experience of two centres |
title_full | Introducing helmet non-invasive ventilation during COVID-19 pandemic: Early experience of two centres |
title_fullStr | Introducing helmet non-invasive ventilation during COVID-19 pandemic: Early experience of two centres |
title_full_unstemmed | Introducing helmet non-invasive ventilation during COVID-19 pandemic: Early experience of two centres |
title_short | Introducing helmet non-invasive ventilation during COVID-19 pandemic: Early experience of two centres |
title_sort | introducing helmet non-invasive ventilation during covid-19 pandemic: early experience of two centres |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941518/ https://www.ncbi.nlm.nih.gov/pubmed/36824605 http://dx.doi.org/10.3389/fmed.2023.1075797 |
work_keys_str_mv | AT chaudhuridipayan introducinghelmetnoninvasiveventilationduringcovid19pandemicearlyexperienceoftwocentres AT sharmarishi introducinghelmetnoninvasiveventilationduringcovid19pandemicearlyexperienceoftwocentres AT burnskarenea introducinghelmetnoninvasiveventilationduringcovid19pandemicearlyexperienceoftwocentres AT piticarujoshua introducinghelmetnoninvasiveventilationduringcovid19pandemicearlyexperienceoftwocentres AT cookdeborahj introducinghelmetnoninvasiveventilationduringcovid19pandemicearlyexperienceoftwocentres AT rochwergbram introducinghelmetnoninvasiveventilationduringcovid19pandemicearlyexperienceoftwocentres |